Pharmacy Audit and Analysis Market Worth $2399.78 Million by 2018.


Posted February 3, 2015 by tonypandrew

The market is expected to grow at a CAGR of 5% to reach $2399.78 million by 2018, from $1882.75 million in 2013, driven by various factors such as the growing need to integrate healthcare systems and investments by healthcare stakeholders.

 
The global pharmacy analysis and audit market is a market with scope for high returns, and it represents a number of opportunities for its stakeholders. The market is expected to grow at a CAGR of 5% to reach $2399.78 million by 2018, from $1882.75 million in 2013, driven by various factors such as the growing need to integrate healthcare systems and investments by healthcare stakeholders.
Browse through the market data tables, figures and detailed ToC on the “Pharmacy Analysis and Audit Market”.
http://www.micromarketmonitor.com/market-report/pharmacy-audit-and-analysis-reports-5966450015.html
Related Reports
North American Pharmacy Audit And Analysis Market

The North American region houses the largest pharmacy analysis and audit market, which is expected to grow at a CAGR of 5.3% to reach $1436.89 million by 2018, from $1109.34 million in 2013. This growth is attributed to the rise in demand for clinical information systems and high return on investment in implementing IT solutions for pharmacy analysis and audit. Customized solutions are preferred in the North American market as different end-users require specific solutions to meet their specific needs. The customized solution costs more and it is impossible for some providers to self-fund these costs. Apart from this, the lack of standard protocols is one of the major factors hindering the growth of this market.
European Pharmacy Audit And Analysis Market

The European region has shown a good growth rate over the past few years for the pharmacy analysis and audit market. The market is expected to grow at a CAGR of 4.4% to reach $544.75 million by 2018, from $438.68 million in 2013. The overall growth of the European pharmacy analysis and audit market is largely driven by the reduction of healthcare costs, the growing need to integrate healthcare systems, and the transformation of healthcare segments. During the Euro-zone crisis, the market was affected by low funds allocation, and the slowing rate of adoption of IT solutions for pharmacy analysis and audit. Additionally, the scarcity of healthcare IT professionals is a factor hindering the growth of this market.

Asian Pharmacy Audit And Analysis Market

The Asian pharmacy analysis and audit market is one of the fastest growing markets, as compared to other regions, and is expected to grow at a CAGR of 5.3% to reach $305.30 million in 2018, from $235.42 million in 2013. This growth is attributed to the increased financial support from governments for implementation of healthcare IT solutions. However, the high costs attached to customized solutions, and lower investments in healthcare IT sector, are the major factors hindering the growth of the market.
Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth
TX 76112
Tel: +1-888-502-0539
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By micromarket monitor
Country United States
Categories Health
Tags Pharmacy Audit and Analysis Market , Pharmacy Audit and Analysis Market size , Pharmacy Audit and Analysis Market share
Last Updated February 3, 2015